期刊文献+

临床药师对冠心病合并糖尿病肾病患者的药学服务 被引量:3

Pharmaceutical Care for Patients with Coronary Heart Disease and Diabetic Nephropathy by Clinical Pharmacists
原文传递
导出
摘要 目的:通过对治疗方案的优化干预和对患者的药学监护,探讨临床药师在合理用药中的作用。方法:对1例基础疾病为冠心病和糖尿病肾病、合并多器官功能衰竭、存在多种药物的禁忌证、经常规药物治疗效果不佳的患者,临床药师结合该患者病理生理状况、经济状况和药物的特点,提出用药调整、补充,对治疗全过程用药进行干预和优化,并对患者进行必要的患者教育。结果与结论:临床药师参与药物治疗方案设计和患者教育,有利于促进药物使用的安全、有效和经济。 OBJECTIVE: To explore the roles of clinical pharmacist in rational drug use by intervening and optimizing therapeu- tic regimen and providing pharmaceutical care. METHODS: Due to primary disease, i.e. coronary heart disease and diabetic ne- phropathy, complicating with multiple organ failure, drug contraindication and unsatisfactory curative efficacy, according to patho- logical state, economic level of the patient and characteristics of drugs, the therapeutic regimen was adjusted and supplemented, medication was optimized and patient education was provided by clinical pharmacists. RESULTS&CONCLUSION: The participa- tion of clinical pharmacist in therapeutic scheme design and patient education contributes to safe, effective and economical drug use.
出处 《中国药房》 CAS CSCD 2013年第6期574-576,共3页 China Pharmacy
关键词 临床药师 药学监护 药物禁忌证 治疗方案优化 Clinical pharmacist Pharmaceutical care Drug contraindication Therapeutic regimen optimization
  • 相关文献

参考文献5

  • 1刘连勇,王菁楠,顾明君.甘精胰岛素与肿瘤[J].药学服务与研究,2010,10(6):458-460. 被引量:2
  • 2周雪红,徐红,张广颖,李玉秀.4例终末期糖尿病肾病透析患者难控制高血糖胰岛素治疗分析[J].山东医药,2010,50(48):88-89. 被引量:2
  • 3Abraham NS,Hlatky MA,Antman EM,et al.ACCF/ACG/AHA 2010 expert consensus document on the concomitant useof proton pump inhibitors and thienopyridines:a focused updateof the ACCF/ACG/AHA 2008 expert consensus document onreducing the gastrointestinal risks of antiplatelet therapy andNSAID use[].Journal of the American College of Cardiology.2010 被引量:1
  • 4DL Campbell-Scherer,LA Green.ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction[].American Family Physician.2009 被引量:1
  • 5Van de Werf F,Bax J,Betriu A,et al.Management of acute myocardial infarction in patients presenting with persis-tent ST-segment elevation:the task force on the manage-ment of ST-Segment elevation acute myocardial infarc-tion of the european society of cardiology[].European Heart Journal.2008 被引量:1

二级参考文献23

  • 1王晶晶,秦岭,陈江华.终末期糖尿病肾病的透析治疗[J].国际移植与血液净化杂志,2006,4(1):20-22. 被引量:11
  • 2卫德强,麻金木.活血化瘀法治疗糖尿病肾病概述[J].吉林中医药,2007,27(2):66-68. 被引量:10
  • 3Ritz E.Managing anaemia and diabetes:a future challenge for nephrologists[J].Nephrol Dial Transplant,2005,20 Suppl 6:vi21-25. 被引量:1
  • 4Bergstrom J,Fürst P,Alvestrand A,et al.Protein and energy intake,nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis[J].Kidney Int,1993,44(5):1048-1057. 被引量:1
  • 5Holmes CJ,Shockley TR.Strategies to reduce glucose exposure in peritoneal dialysis patients[J].Perit Dial Int,2000,20 Suppl 2:S37-41. 被引量:1
  • 6U. Grouven,L. G. Hemkens,R. Bender,P. T. Sawicki.Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter][J]. Diabetologia . 2010 (1) 被引量:1
  • 7P. D. Home,P. Lagarenne.Combined randomised controlled trial experience of malignancies in studies using insulin glargine[J]. Diabetologia . 2009 (12) 被引量:1
  • 8Mayer D,Shukla A,Enzmann H.Proliferative effects of insu-lin analogues on mammary epithelial cells. Arch PhysiolBiochem . 2008 被引量:1
  • 9Weinstein D,Si mon M,Yehezkel E,et al.Insulin analoguesdisplay IGF-Ⅰ-like mitogenic and anti-apoptotic activities incultured cancer cells. Diabetes Metabolism Reviews . 2009 被引量:1
  • 10Jonasson J M,Ljung R,Talback M,et al.Insulin glargine useand short-termincidence of malignancies-a population-basedfollow-up study in Sweden. Diabetologia . 2009 被引量:1

共引文献2

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部